The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.
Tag:
His-Avi
UniProt:
QHD43416.1
Buffer:
Lyophilized from 0.22um filtered solution in 20mM PB (pH 7.4). 5% trehalose is added as a protectant before lyophilization.
Source:
Recombinant SARS-COV-2 Spike S1 (D614G) Protein protein is expressed in HEK293 with His-Avi. It contains the amino acid sequence of Gln14-Arg683.
Expression System:
HEK293
Purity:
> 95% as determined by Bis-Tris PAGE, > 95% as determined by HPLC
* VAT and and shipping costs not included. Errors and price changes excepted
